Overview
What is Doheny Eye Institute?
The Doheny Eye Institute (DEI) is a renowned nonprofit organization situated in Pasadena, California, dedicated to enhancing human eyesight through research, education, and clinical care. Guided by objectives to expand knowledge of the human eye and its ailments, DEI conducts research on retinal degeneration, molecular genetics of inherited eye diseases, retinal vascular stiffness, and mitochondrial dysfunction. Notably, DEI has initiated collaborations with UCLA for a 99-year affiliation to further their mission. In recent studies, DEI is examining the mechanisms responsible for Age-Related Macular Degeneration (AMD) and developing new therapies using artificial intelligence and gene therapy. Additionally, they have pioneered advanced imaging technologies, such as Adaptive Optics Near-Confocal Ophthalmoscopy (AONCO), to assess retinal microcirculation and detect age- and disease-related changes. The organization's commitment to excellence in ophthalmology care and groundbreaking research continues to drive innovative solutions for improving eyesight.
Official website here: www.doheny.org
What are the reviews and ratings of this charity?
Charity Navigator Rating 90% - Four-Star out of Four Star Rating
Doheny Eye Institute has demonstrated strong performance with a 90% overall rating from Charity Navigator, indicating robust accountability and financial stewardship. The organization boasts an impressive score of 100 in Leadership & Adaptability, highlighting its capacity to navigate challenges effectively. With 92% of its board members being independent, the institute showcases a commitment to governance that prioritizes transparency and integrity.
Strengths of the Doheny Eye Institute include a high Culture & Community score of 98, reflecting its positive internal environment and community engagement. Financially, the institute has an outstanding Liabilities to Assets Ratio of 2.15% and has received top marks in areas such as audit oversight and conflict of interest policies. Furthermore, the organization invests in leadership development, as evidenced by funding staff to attend relevant conferences, which contributes to a knowledgeable and capable team.
However, the program expense ratio stands at 59.82%, which, while generally favorable, suggests that a significant portion of the budget is allocated elsewhere. This may raise questions about the level of investment in direct program services relative to administrative costs. Overall, the Doheny Eye Institute is well-rated and appears to be effectively managed, but potential donors may want to consider the balance between program expenses and overall financial health.
This AI summary has been generated from information found on Charity Navigator.
Is Doheny Eye Institute legitimate?
Doheny Eye Institute is a legitimate nonprofit organization registered as a 501(c)(3) entity. Doheny Eye Institute submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $2,412,502
Professional Fundraising Fees: $0
Other Salaries and Wages: $6,837,342
For more financial information, click here
Official website here: www.doheny.org
What is the mission statement of Doheny Eye Institute?
The Doheny Eye Institute is dedicated to advancing knowledge about the human eye, its conditions, and diseases through research. This knowledge is then disseminated through education, training, and community service. The ultimate goal is to facilitate the application of research to improve patient care and foster further research. Research areas with long-term focus include retinal and macular degeneration, molecular genetics of inherited retinal diseases, and retinal vascular stiffness. Recent studies are focused on understanding the mechanisms responsible for age-related macular degeneration and developing new therapies for this disease. The institute also employs cutting-edge imaging technology and artificial intelligence to interpret retinal images and predict disease progression.
Official website here: www.doheny.org
Who is the CEO of Doheny Eye Institute?
Marissa Goldberg is the CEO of Doheny Eye Institute The CEO's salary of Doheny Eye Institute is $551,250 and their total compensation is $625,491.
Official website here: www.doheny.org
What is the revenue of Doheny Eye Institute?
Doheny Eye Institute's revenue in 2024 was $25,100,576.
Official website here: www.doheny.org
Who are the executives of Doheny Eye Institute and what are their salaries?
The average compensation at Doheny Eye Institute during 2024 was $68,517. There are 135 employees and 25 volunteers at Doheny Eye Institute.
Here are 21 key members and their salaries (Doheny Eye Institute's CEO's salary is $551,250 and their total compensation is $625,491):
- Compensation: $551,250
- Related: $0
- Other: $74,241
- Compensation: $425,000
- Related: $0
- Other: $16,512
- Compensation: $277,807
- Related: $0
- Other: $28,405
- Compensation: $225,000
- Related: $0
- Other: $27,039
- Compensation: $191,390
- Related: $0
- Other: $35,027
- Compensation: $175,610
- Related: $0
- Other: $45,112
- Compensation: $171,518
- Related: $0
- Other: $28,826
- Compensation: $103,301
- Related: $0
- Other: $36,464
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Official website here: www.doheny.org
Where can I find the form 990 for Doheny Eye Institute?
Doheny Eye Institute's most recent form 990 was submitted in 2024 and can be accessed here.
Official website here: www.doheny.org
Learn more at the official website: www.doheny.org
Mission Statement of Doheny Eye Institute
The Doheny Eye Institute, a leading nonprofit organization, is dedicated to the conservation, improvement, and restoration of human eyesight. Established in the spirit of Mrs. Doheny's vision in 1947, this institute aims to increase knowledge of the human eye and its conditions and diseases through rigorous research. Guided by this objective, Doheny Eye Institute conducts research on retinal degeneration, including age-related macular degeneration (AMD), and explores the use of advanced retinal imaging and artificial intelligence for diagnosis and treatment.
The organization's mission extends beyond research. It also involves the transmission of acquired knowledge through education, training, and community service. Doheny Eye Institute's research activities, such as studies on retinal pigment epithelium, molecular genetics of inherited retinal diseases, and retinal vascular stiffness, are focused on improving patient care and fostering further research. By applying the findings of their studies, they aim to develop new therapies for AMD and other eye diseases.
Doheny Eye Institute's researchers are currently investigating the mechanisms responsible for the development of AMD, a leading cause of blindness in individuals over 60 years old in the US. They are studying retinal cells from patients with specific genetic defects in genes involved in the immune system and another gene of unknown function but with a significant impact on AMD. The insights gained from these studies will be critical in developing new therapies for AMD that target the root cause of the disease.
Additionally, Doheny Eye Institute scientists are using artificial intelligence to develop faster ways to interpret retinal images and predict new Stargardt atrophy or progression over time. They have also developed cutting-edge imaging technology, such as an adaptive optics near-confocal ophthalmoscope, which enables precise evaluation of the dynamic movement of erythrocytes within retinal capillaries and helps gain a better understanding of the higher-order hemodynamics in normal human retinal capillaries. This research is essential as it will lead to the development of new biomarkers for detecting age- and disease-related changes in the retinal microcirculation.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
Doheny Eye Institute significantly advances the understanding and treatment of various eye conditions, with a strong emphasis on research, education, and clinical care. Its mission focuses on enhancing human eyesight through innovative scientific inquiry and community engagement. Key research initiatives target prevalent issues such as age-related macular degeneration (AMD) and diabetic retinopathy, employing cutting-edge technologies like artificial intelligence and advanced imaging methods to improve diagnostic accuracy and treatment efficacy.
The Institute's collaboration with the University of California, Los Angeles (UCLA) ensures that the latest research findings are translated into high-quality clinical care, benefiting patients directly. For instance, Doheny's exploration of genetic mutations that heighten the risk of AMD aims to uncover new therapeutic pathways, while its development of novel imaging technologies allows for unprecedented insights into retinal health and disease progression.
Through interdisciplinary approaches that integrate insights from genetics, vascular biology, and cellular imaging, Doheny Eye Institute is not only enhancing our understanding of eye diseases but also paving the way for breakthroughs in pathology and treatment. The impact extends beyond individual patient care to broader public health implications, as its findings contribute to the global effort to mitigate vision loss and enhance the quality of life for individuals affected by ocular diseases.
This information is meant to be a general summary of Doheny Eye Institute. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2024.
- Investment Income: $3,471,594
- Program Service Revenue: $6,338,227
- Gross Receipts: $49,960,685
Assets and Liabilities:
- Total Assets: $229,360,664
- Total Liabilities: $4,674,006
- Net Assets: $224,686,658
Want to help this charity, for free? You can click here to learn more about Give Freely
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
CONTRACTS
Revenue
$5,451,653
PASS THROUGH AWARDS
Revenue
$484,424
OTHER REVENUE
Revenue
$402,150
Organization Details
Founding Year
1947
Principal Officer
Marissa Goldberg
Website
www.doheny.orgNTEE Category
Code: G40 - Disease
If you are a representative of Doheny Eye Institute and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.